Mkt Cap$2.24T-0.24%
24h Vol$62.47B
BTC Dom56.1%
ETH Dom9.6%
F&G22Extreme Fear
BTC$62,769.00-0.20% ETH$1,795.23+0.98% USDT$0.9988-0.02% BNB$570.12+0.34% USDC$0.9999+0.01% XRP$1.07-0.75% SOL$75.21-1.19% TRX$0.3248-0.76% FIGR_HELOC$1.03+1.91% HYPE$63.84-1.72% DOGE$0.0721-0.02% USDS$0.9999+0.02% RAIN$0.0142-1.58% LEO$9.55+0.30% ZEC$507.33-1.11% WBT$55.10+0.04% BTC$62,769.00-0.20% ETH$1,795.23+0.98% USDT$0.9988-0.02% BNB$570.12+0.34% USDC$0.9999+0.01% XRP$1.07-0.75% SOL$75.21-1.19% TRX$0.3248-0.76% FIGR_HELOC$1.03+1.91% HYPE$63.84-1.72% DOGE$0.0721-0.02% USDS$0.9999+0.02% RAIN$0.0142-1.58% LEO$9.55+0.30% ZEC$507.33-1.11% WBT$55.10+0.04%
News

Glenview Capital

Total Stories
1
Section
Glenview Capital
CVS Faces Potential Activist Pressure Following Share Price Drop
Market Analysis

CVS Faces Potential Activist Pressure Following Share Price Drop

Hedge fund Glenview Capital plans to meet with CVS Health executives to propose operational changes amid the company's struggling stock performance and financial challenges.

Tim FriesSep 30, 20242 min read